GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)
Close on Nov 16, 2026Market cap $1.52BP/E –Yield –
GeneDx gross margin
Gross margin is gross profit as a percentage of revenue.
GeneDx's gross margin for the twelve months ending Jun 30, 2026 was 69.4%. For fiscal 2025 it was 69.7%, against 63.6% the year before. The highest annual figure on record is 69.7% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 69.7% | +6.1 |
| FY2024 | Dec 31, 2024 | 63.6% | +19.2 |
| FY2023 | Dec 31, 2023 | 44.4% | +55.8 |
| FY2022 | Dec 31, 2022 | -11.4% | −3.6 |
| FY2021 | Dec 31, 2021 | -7.8% | −10.1 |
| FY2020 | Dec 31, 2020 | 2.2% | −40.0 |
| FY2019 | Dec 31, 2019 | 42.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 68.4% | −0.7 |
| Q1 FY2026 | Mar 31, 2026 | 66.7% | −0.4 |
| Q4 FY2025 | Dec 31, 2025 | 69.6% | +0.4 |
| Q3 FY2025 | Sep 30, 2025 | 72.4% | +10.2 |
| Q2 FY2025 | Jun 30, 2025 | 69.0% | +8.1 |
| Q1 FY2025 | Mar 31, 2025 | 67.1% | +7.2 |
| Q4 FY2024 | Dec 31, 2024 | 69.2% | +15.7 |
| Q3 FY2024 | Sep 30, 2024 | 62.2% | +14.8 |
| Q2 FY2024 | Jun 30, 2024 | 60.9% | +22.4 |
| Q1 FY2024 | Mar 31, 2024 | 59.9% | +24.6 |
| Q4 FY2023 | Dec 31, 2023 | 53.6% | +80.2 |
| Q3 FY2023 | Sep 30, 2023 | 47.4% | +31.1 |
| Q2 FY2023 | Jun 30, 2023 | 38.5% | +120.3 |
| Q1 FY2023 | Mar 31, 2023 | 35.3% | +24.9 |
| Q4 FY2022 | Dec 31, 2022 | -26.6% | −21.8 |
| Q3 FY2022 | Sep 30, 2022 | 16.3% | +35.5 |
| Q2 FY2022 | Jun 30, 2022 | -81.8% | −79.4 |
| Q1 FY2022 | Mar 31, 2022 | 10.4% | +17.2 |
| Q4 FY2021 | Dec 31, 2021 | -4.9% | +4.0 |
| Q3 FY2021 | Sep 30, 2021 | -19.2% | −31.1 |
| Q2 FY2021 | Jun 30, 2021 | -2.5% | +12.2 |
| Q1 FY2021 | Mar 31, 2021 | -6.7% | −27.1 |
| Q4 FY2020 | Dec 31, 2020 | -8.9% | – |
| Q3 FY2020 | Sep 30, 2020 | 11.9% | – |
| Q2 FY2020 | Jun 30, 2020 | -14.6% | – |
| Q1 FY2020 | Mar 31, 2020 | 20.4% | – |
See a number that looks wrong?